N. M. Yarosh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
N. M. Yarosh has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Zoya Alexandrovna Goncharova
Rostov State Medical University, Ministry of Health of Russia
3 shared publications - E. A. Markova
Rostov State Medical University
2 shared publications - A. I. Afanas’eVa
Altai State Medical University
1 shared publication - A.M. Prilenskaya
AO MSCH «Neftyanik
1 shared publication - E. Yu. Elchaninova
Altai State Medical University
1 shared publication - Ekaterina Valerievna Popova
City Clinical Hospital No. 24
1 shared publication
Latest Publications
- Open Access
- 26 March 2026
- Published by Rostov State Medical University in Medical Herald of the South of Russia
- Vol. 17 (1) , 87-96
Clinical and immunological aspects of the first attack of multiple sclerosis (clinically isolated syndrome)
Objective : to identify clinical and immunological predictors of early conversion in patients with CIS. Materials and methods : analysis of medical records and laboratory data of 320 patients, data processing - one- and two-way analysis of variance (ANOVA), nonparametric chi-square test, parametric and nonparametric (Spearman) correlation analysis, Mann-Whitney rank test. Results : age of onset: 13–71 years, mean — 36.4±8 years; Me=36 years. In 60 patients (18.7%) the onset was at the age of 50 years and older. Polyfocal onset was detected in 84.4%, in most patients conversion occurred after 12 months or more. In innate immunity: an increase in CD16+Gr+, % 7.8 [5.2; 9.1], CD14+289+ 12 [4; 20], inversion of the HBT test 155 [139; 171] (p < 0.05). In adaptive immunity: an increase in CD3+HLA DR+, % 3 [2; 5.4], CD8+Gr+ 20 [15; 27], CD19+, % 9 [7; 12], an increase in the CIC, AU. 60 [47;84] (p < 0.05), decrease in CD4+CD25+, % 1.3 [1.0;2.2], CD19+CD5+, % 0.6 [0.3;0.9] (p < 0.05). a wide range of the age of onset was revealed, with a tendency towards an increase in the average age, and prevalence of polyfocal debut. In innate immunity, an increase in monocytes expressing CD14+289+ with a decrease in the ability of antibacterial protection, a decrease in the activation capacity of monocytes, an increase in the cytotoxic functions of natural killers, a decrease in the adaptive reserves of the neutrophil link with inversion of the NBT test. Changes in adaptive immunity lead to inversion of IRI (an increase in cells with a cytotoxic effect, a violation of the B1/B2 lymphocyte ratio and their discoordination). Discoordination of antibody production processes in the humoral immunity. Conclusion : clinical and immunological markers of early conversion of CIS to MS have been identified.
- 26 March 2026
- Published by Rostov State Medical University in Medical Herald of the South of Russia
- Vol. 17 (1) , 87-96
Open AccessClinical and immunological aspects of the first attack of multiple sclerosis (clinically isolated syndrome)
Objective : to identify clinical and immunological predictors of early conversion in patients with CIS. Materials and methods : analysis of medical records and laboratory data of 320 patients, data processing - one- and two-way analysis of variance (ANOVA), nonparametric chi-square test, parametric and nonparametric (Spearman) correlation analysis, Mann-Whitney rank test. Results : age of onset: 13–71 years, mean — 36.4±8 years; Me=36 years. In 60 patients (18.7%) the onset was at the age of 50 years and older. Polyfocal onset was detected in 84.4%, in most patients conversion occurred after 12 months or more. In innate immunity: an increase in CD16+Gr+, % 7.8 [5.2; 9.1], CD14+289+ 12 [4; 20], inversion of the HBT test 155 [139; 171] (p < 0.05). In adaptive immunity: an increase in CD3+HLA DR+, % 3 [2; 5.4], CD8+Gr+ 20 [15; 27], CD19+, % 9 [7; 12], an increase in the CIC, AU. 60 [47;84] (p < 0.05), decrease in CD4+CD25+, % 1.3 [1.0;2.2], CD19+CD5+, % 0.6 [0.3;0.9] (p < 0.05). a wide range of the age of onset was revealed, with a tendency towards an increase in the average age, and prevalence of polyfocal debut. In innate immunity, an increase in monocytes expressing CD14+289+ with a decrease in the ability of antibacterial protection, a decrease in the activation capacity of monocytes, an increase in the cytotoxic functions of natural killers, a decrease in the adaptive reserves of the neutrophil link with inversion of the NBT test. Changes in adaptive immunity lead to inversion of IRI (an increase in cells with a cytotoxic effect, a violation of the B1/B2 lymphocyte ratio and their discoordination). Discoordination of antibody production processes in the humoral immunity. Conclusion : clinical and immunological markers of early conversion of CIS to MS have been identified.
- 5 October 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (9) , 76-82
Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить степень тяжести и частоту возникновения инфузионных реакций (ИР) на фоне терапии препаратом алемтузумаб у пациентов с высокоактивным течением рассеянного склероза (ВАРС) в российской популяции. МАТЕРИАЛ И МЕТОДЫ В данном ретроспективном исследовании были проанализированы данные 50 пациентов с ВАРС из 6 региональных центров РС России, получивших по два курса алемтузумаба в период с 2018 по 2022 г. РЕЗУЛЬТАТЫ Из всех ИР чаще всего отмечалось появление высыпаний по типу крапивницы (n=27), преимущественно легкой степени тяжести (70,6%). На втором месте по частоте возникновения оказалась головная боль (n=17, 34%). При сравнении группы пациентов, которым проводилась музыкотерапия (МТ), и тех, кто получал алемтузумаб без МТ, статистически значимой разницы частоты и тяжести ИР не было. ЗАКЛЮЧЕНИЕ У всех пациентов были зарегистрированы ИР разной степени выраженности. Отмечалось уменьшение балла по шкале инвалидизации EDSS. МТ не оказала влияния на возникновение ИР и степень их выраженности.
- 5 October 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (9) , 76-82
Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить степень тяжести и частоту возникновения инфузионных реакций (ИР) на фоне терапии препаратом алемтузумаб у пациентов с высокоактивным течением рассеянного склероза (ВАРС) в российской популяции. МАТЕРИАЛ И МЕТОДЫ В данном ретроспективном исследовании были проанализированы данные 50 пациентов с ВАРС из 6 региональных центров РС России, получивших по два курса алемтузумаба в период с 2018 по 2022 г. РЕЗУЛЬТАТЫ Из всех ИР чаще всего отмечалось появление высыпаний по типу крапивницы (n=27), преимущественно легкой степени тяжести (70,6%). На втором месте по частоте возникновения оказалась головная боль (n=17, 34%). При сравнении группы пациентов, которым проводилась музыкотерапия (МТ), и тех, кто получал алемтузумаб без МТ, статистически значимой разницы частоты и тяжести ИР не было. ЗАКЛЮЧЕНИЕ У всех пациентов были зарегистрированы ИР разной степени выраженности. Отмечалось уменьшение балла по шкале инвалидизации EDSS. МТ не оказала влияния на возникновение ИР и степень их выраженности.
- 21 July 2021
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 26 (3) , 34-39
Еarly diagnosis of multiple sclerosis: experience with the use of class G oligoclonal immunoglobulin
The article presents the literature review and our experience in early diagnosis of multiple sclerosis based on the updated McDonald criteria of 2017. The study included 256 patients with clinic symptoms of probable idiopathic infl ammatory demyelinating disease, including rare and atypical forms of demyelination. As a result of the study the sensitivity and specifi city of the determination of oligoclonal immunoglobulin G in the population of Rostov-on-Don was described for the fi rst time, including dependence of the duration of the disease. The relationship of clinical and MRI features of the fi rst attack of the disease with the probability of determining oligoclonal IgG in the cerebrospinal fl uid is refl ected
- 21 July 2021
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 26 (3) , 34-39
Еarly diagnosis of multiple sclerosis: experience with the use of class G oligoclonal immunoglobulin
The article presents the literature review and our experience in early diagnosis of multiple sclerosis based on the updated McDonald criteria of 2017. The study included 256 patients with clinic symptoms of probable idiopathic infl ammatory demyelinating disease, including rare and atypical forms of demyelination. As a result of the study the sensitivity and specifi city of the determination of oligoclonal immunoglobulin G in the population of Rostov-on-Don was described for the fi rst time, including dependence of the duration of the disease. The relationship of clinical and MRI features of the fi rst attack of the disease with the probability of determining oligoclonal IgG in the cerebrospinal fl uid is refl ected